IVVvsPBE
iShares Core S&P 500 ETF against Invesco Dynamic Biotechnology & Genome ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IVV | PBE | |
|---|---|---|
| Expense ratio | 0.030% | 0.58% |
| Assets | $896.9B | $423M |
| Net flow, 1 month | +$19.2B | +$930K |
| Net flow, 1 year | +$73.1B | +$113M |
| Return, YTD | +14.0% | +15.4% |
| Return, 1 year | +16.1% | +31.8% |
| Avg daily volume | 9.3M | 14K |
| Holdings | 507 | 31 |
| Listed | May 15, 2000 | Jun 23, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS